Table 2.
EMI PATIENTS (%) | NON EMI PATIENTS (%) | P VALUE | |
---|---|---|---|
CD56−/CD117− | 10 (29) | 28 (14%) | 0.046 |
CD56+/CD117− | 5 (14%) | 9 (5%) | 0.042 |
CD56−/CD117+ | 16 (46%) | 145 (74%) | 0.023 |
CD117− | 15 (43%) | 37 (19%) | 0.0035 |
CD56+ | 9 (26%) | 24 (12%) | 0.0612 |
EMI PATIENTS (%) | NON EMI PATIENTS (%) | P VALUE | |
---|---|---|---|
CD56−/CD117− | 10 (29) | 28 (14%) | 0.046 |
CD56+/CD117− | 5 (14%) | 9 (5%) | 0.042 |
CD56−/CD117+ | 16 (46%) | 145 (74%) | 0.023 |
CD117− | 15 (43%) | 37 (19%) | 0.0035 |
CD56+ | 9 (26%) | 24 (12%) | 0.0612 |